3085 Second-line afatinib vs erlotinib in patients with advanced squamous cell carcinoma (SCC) of the lung: patient-reported outcome (PRO) data from the global LUX-Lung 8 (LL8) Phase III trial

European Journal of Cancer ◽

10.1016/s0959-8049(16)31726-9 ◽

2015 ◽

Vol 51 ◽

pp. S626-S627

Author(s):

S. Popat ◽

E. Felip ◽

M. Cobo ◽

A. Fulop ◽

C. Dayen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Patient Reported Outcome ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

Phase Iii Trial ◽

Patient Reported

Download Full-text

LUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung

Annals of Oncology ◽

10.1093/annonc/mdx091.022 ◽

2017 ◽

Vol 28 ◽

pp. ii37 ◽

Cited By ~ 1

Author(s):

J.C.-H. Yang ◽

G. Goss ◽

E. Felip ◽

S. Lu ◽

A. Ardizzoni ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

Phase Iii Trial ◽

Trial Analysis ◽

Term Response

Download Full-text

Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial

10.1183/13993003.congress-2015.oa265 ◽

2015 ◽

Author(s):

Shirish Gadgeel ◽

Jean-Charles Soria ◽

Enriqueta Felip ◽

Manuel Cobo ◽

Shun Lu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Line Treatment ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

Phase Iii Trial

Download Full-text

LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy

CHEST Journal ◽

10.1378/chest.2272584 ◽

2015 ◽

Vol 148 (4) ◽

pp. 585A

Author(s):

Vera Hirsh ◽

Shirish Gadgeel ◽

Jean-Charles Soria ◽

Enriqueta Felip ◽

Manuel Cobo ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Line Treatment ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

First Line ◽

Phase Iii Trial ◽

Platinum Based Chemotherapy

Download Full-text

Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8100 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8100-8100

Author(s):

Shirish M. Gadgeel ◽

Manuel Cobo Dols ◽

Enriqueta Felip ◽

Jean-Charles Soria ◽

Ki Hyeong Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Patient Reported Outcome ◽

Phase Iii ◽

Line Treatment ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

First Line ◽

Platinum Based Chemotherapy ◽

Patient Reported

Download Full-text

Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial

Annals of Oncology ◽

10.1093/annonc/mdu438.30 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Cited By ~ 3

Author(s):

J-P. Machiels ◽

R.I. Haddad ◽

J. Fayette ◽

L.F. Licitra ◽

M. Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase Iii ◽

Line Treatment ◽

Second Line ◽

Primary Efficacy ◽

Phase Iii Trial ◽

Head Neck

Download Full-text

Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: Neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(04)01100-9 ◽

2004 ◽

Vol 60 ◽

pp. S139-S139 ◽

Cited By ~ 1

Author(s):

M STUSCHKE ◽

M STAHL ◽

H WILKE ◽

M WALZ ◽

S SEEBER ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Neoadjuvant Radiochemotherapy ◽

Advanced Squamous Cell Carcinoma ◽

Carcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Definitive Radiochemotherapy

Download Full-text

OA23.03 Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.362 ◽

2017 ◽

Vol 12 (1) ◽

pp. S334-S335 ◽

Cited By ~ 1

Author(s):

Glenwood Goss ◽

Manuel Cobo ◽

Shun Lu ◽

Kostas Syrigos ◽

Alessandro Morabito ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line

Download Full-text

Afatinib (A) Vs Erlotinib (E) as Second-Line Treatment of Patients (PTS) with Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (LL8), a Phase Iii Global Trial

Annals of Oncology ◽

10.1093/annonc/mdv050.12 ◽

2015 ◽

Vol 26 ◽

pp. i29 ◽

Cited By ~ 3

Author(s):

G.D. Goss ◽

E. Felip ◽

M. Cobo ◽

S. Lu ◽

V. Georgoulias ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Line Treatment ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

First Line ◽

Platinum Based Chemotherapy

Download Full-text

327 oral Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)82193-5 ◽

2004 ◽

Vol 73 ◽

pp. S148

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Neoadjuvant Radiochemotherapy ◽

Advanced Squamous Cell Carcinoma ◽

Carcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Definitive Radiochemotherapy

Download Full-text

Evaluation of the VeriStrat ® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Lung Cancer ◽

10.1016/j.lungcan.2017.05.010 ◽

2017 ◽

Vol 109 ◽

pp. 101-108 ◽

Cited By ~ 17

Author(s):

Shirish Gadgeel ◽

Glenwood Goss ◽

Jean-Charles Soria ◽

Enriqueta Felip ◽

Vassilis Georgoulias ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Serum Protein ◽

Squamous Cell ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line

Download Full-text